Clinical Trials Directory

Trials / Completed

CompletedNCT01196221

Technical Innovation Protocol for MR & US Plaque Imaging: Reproducibility.

Technical Innovation Protocol for Carotid Plaque Imaging by 3.0 Tesla MRI, MRS and Ultrasound: Reproducibility.

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to develop non-invasive MRI, and MRS approaches that will quantify the plaque composition and lipid content of plaques and will have the potential for repeated in vivo measurements. Simultaneously this study aims to develop US plaque imaging as a screening tool to select plaque phenotypes of interest for clinical trials (a large LRNC). For plaque composition imaging by MRI the researchers aim to increase scan resolution and decrease scan time. For quantifying plaque lipid content the researchers aim to develop an MRS protocol. Subsequently, the researchers intend to study the reproducibility of plaque composition and lipid content measurements by MRI, MRS and Ultrasound in subjects that have carotid artery plaques.

Conditions

Timeline

Start date
2009-11-01
Primary completion
2010-08-01
Completion
2010-09-01
First posted
2010-09-08
Last updated
2010-09-08

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01196221. Inclusion in this directory is not an endorsement.

Technical Innovation Protocol for MR & US Plaque Imaging: Reproducibility. (NCT01196221) · Clinical Trials Directory